万达制药获FDA批准推出“扩展产品线”抗精神病药物。
Vanda gets FDA approval for ‘franchise-extending’ antipsychotic
生物技术与制药领域的最新动态
Vanda gets FDA approval for ‘franchise-extending’ antipsychotic
Grail's cancer test faces new uncertainty after UK study
Supreme Court steps in: Trump's emergency tariffs struck down
Ionis scraps early candidate for Alzheimer’s in people with Down syndrome
Ionis scraps Alzheimer’s drug for people with Down syndrome
Grail’s multi-cancer early detection test misses study goal
Supreme Court invalidates Trump tariffs based on emergency powers
Supreme Court tariff ruling lets stand Trump’s authority to target pharma
Roche gets FDA decision date on closely watched breast cancer drug
San Diego Upstart Drops $100 Genome Bombshell on Illumina - Hoodline
What Are Wall Street Analysts' Target Price for Waters Corporation Stock? - Barchart.com
In the clinic for Feb. 20, 2026
Other news to note for Feb. 20, 2026
Regulatory actions for Feb. 20, 2026
Biopharma money raised: Jan. 1-Feb. 19, 2026
Money raised by biopharma
TXG: UBS Raises Price Target for 10x Genomics to $20 | TXG Stock News - GuruFocus
Structure of the lysosomal KICSTOR-GATOR1-SAMTOR nutrient-sensing supercomplex
Symbiotic entrenchment through ecological Catch-22
Grail stock craters as key NHS-Galleri cancer blood test trial fails to hit primary endpoint